SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-18-020646
Filing Date
2018-11-14
Accepted
2018-11-13 20:10:59
Documents
15
Period of Report
2018-11-12
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bcda20181113_8k.htm 8-K 18748
2 EXHIBIT 99.1 ex_129726.htm EX-99.1 14581
3 EXHIBIT 99.2 ex_129809.htm EX-99.2 7220
4 a12.jpg GRAPHIC 76963
5 a11.jpg GRAPHIC 83895
6 a10.jpg GRAPHIC 103791
7 a09.jpg GRAPHIC 92367
8 a08.jpg GRAPHIC 89918
9 a07.jpg GRAPHIC 82770
10 a06.jpg GRAPHIC 93564
11 a05.jpg GRAPHIC 78641
12 a04.jpg GRAPHIC 101628
13 a03.jpg GRAPHIC 110732
14 a02.jpg GRAPHIC 112498
15 a01.jpg GRAPHIC 140841
  Complete submission text file 0001437749-18-020646.txt   1650794
Mailing Address 125 SHOREWAY ROAD SUITE B SAN CARLOS CA 94070
Business Address 125 SHOREWAY ROAD SUITE B SAN CARLOS CA 94070 650-226-0123
BioCardia, Inc. (Filer) CIK: 0000925741 (see all company filings)

IRS No.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21419 | Film No.: 181180003
SIC: 2836 Biological Products, (No Diagnostic Substances)